-
CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. DC
- 3:04-cv-04030
- D.N.J.
- Filed: 08/19/2004
- Closed: 02/01/2010
- Latest Docket Entry: 02/01/2010
- Judge: Freda L. Wolfson
+1
- PACER
3
Plaintiffs
1
Defendant
1
Accused
Product
1
Patent-in-Suit
1,993
Days in
Litigation
-
CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. DC
- 3:04-cv-04030
- D.N.J.
- Filed: 08/19/2004
- Closed: 02/01/2010
- Latest Docket Entry: 02/01/2010
- Judge: Freda L. Wolfson
+1
- PACER
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Referred Judge
Assigned Judge
Outcome Summary
Patent Information
-
Infringement
Teva Pharmaceutical Europe BV
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Dexmethylphenidate hydrochloride capsules, 40 mgGeneric Focalin XR | US 5,908,850 A | All Asserted Claims |
Infringement
Entry 188
|